Clinical Trial Update: A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial sponsored by Mirador Therapeutics is evaluating therapies for inflammatory bowel disease, including ulcerative colitis and Crohn's dise…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Inflammatory Bowel Disease
• Ulcerative Colitis

Snippet

Sponsor: Mirador Therapeutics, Inc. | Conditions: Inflammatory Bowel Disease (IBD), Ulcerative Colitis (UC) | Phase 2 | Status: RECRUITING